Skip to content

Insider · CIK 0001219855

BARRETT M JAMES

Reports to the SEC for 68 companies · BALTIMORE, MD

Transactions

50

Companies

68

Filings

12

CIK

0001219855

Forms 4 and 5

Insider transactions

50 trades
DateCompanyValue
2019-05-30SENSSenseonics Holdings, Inc. · Stock Option (right to buy)A Award—
2019-01-02SENSSenseonics Holdings, Inc.A Award+$9,748.56
2018-10-11Clovis Oncology, Inc.Stock Option (Right to Buy)A Award—
2018-10-01SENSSenseonics Holdings, Inc.A Award+$9,747.38
2018-09-07ADAPAdaptimmune Therapeutics PLCP Purchase+$5M
2018-07-30Liquidia Technologies IncSeries D Preferred StockC Conversion—
2018-07-30Liquidia Technologies IncP Purchase+$6M
2018-07-30Liquidia Technologies IncWarrant to purchase Series D Preferred StockJ Other—
2018-07-30Liquidia Technologies IncC Conversion—
2018-07-30Liquidia Technologies IncWarrant to purchase Common StockJ Other—
2018-07-30Liquidia Technologies IncSeries B Preferred StockC Conversion—
2018-07-30Liquidia Technologies IncC Conversion—
2018-07-30Liquidia Technologies IncC Conversion—
2018-07-30Liquidia Technologies IncSeries C Preferred StockC Conversion—
2018-07-02SENSSenseonics Holdings, Inc.A Award+$9,746
2018-06-15KINETA, INC./DEStock Option (Right to Buy)A Award—
2018-05-30SENSSenseonics Holdings, Inc. · Stock Option (right to buy)A Award—
2018-05-25ARDXARDELYX, INC.A Award+$1.67M
2018-05-18CBIOCRESCENT BIOPHARMA, INC. · Stock Option (right to buy)A Award—
2018-05-10CBIOCRESCENT BIOPHARMA, INC.X Exercise of In-Money+$71.3K
2018-05-10CBIOCRESCENT BIOPHARMA, INC.S Sale−$98.5K
2018-05-10CBIOCRESCENT BIOPHARMA, INC.S Sale−$71.3K
2018-05-10CBIOCRESCENT BIOPHARMA, INC.X Exercise of In-Money+$98.5K
2018-05-10CBIOCRESCENT BIOPHARMA, INC. · Warrant to Purchase Common Stock (right to buy)X Exercise of In-Money—
2018-05-10CBIOCRESCENT BIOPHARMA, INC. · Warrant to Purchase Common Stock (right to buy)X Exercise of In-Money—
2018-05-01MULESOFT, INCU Disposition from Tender—
2018-05-01MULESOFT, INCClass B Common StockC Conversion—
2018-05-01MULESOFT, INCC Conversion—
2018-04-23Surface Oncology, Inc.P Purchase+$2M
2018-04-23Surface Oncology, Inc.Series A Preferred StockC Conversion—
2018-04-23Surface Oncology, Inc.C Conversion—
2018-04-02SENSSenseonics Holdings, Inc.A Award+$9,749.5
2018-03-27Tracon Pharmaceuticals, Inc.P Purchase+$1.91M
2018-03-27ADAPAdaptimmune Therapeutics PLCP Purchase+$11.5M
2018-03-27Tracon Pharmaceuticals, Inc.Warrant to Purchase Common StockP Purchase+$88.5K
2018-03-26ADAPAdaptimmune Therapeutics PLCP Purchase+$1.09M
2018-03-23ADAPAdaptimmune Therapeutics PLCP Purchase+$572K
2018-03-22ADAPAdaptimmune Therapeutics PLCP Purchase+$1.66M
2018-03-21ADAPAdaptimmune Therapeutics PLCP Purchase+$190K
2018-03-06TESARO, Inc.P Purchase+$756K
2018-03-05TESARO, Inc.P Purchase+$94.6K
2018-03-05TESARO, Inc.P Purchase+$1.03M
2018-03-05TESARO, Inc.P Purchase+$1.77M
2018-03-02TESARO, Inc.P Purchase+$352K
2018-03-02TESARO, Inc.P Purchase+$231K
2018-03-02TESARO, Inc.P Purchase+$1.43M
2018-03-02TESARO, Inc.P Purchase+$1.02M
2018-02-13APPNAPPIAN CORPJ Other—
2018-02-13APPNAPPIAN CORPC Conversion—
2018-02-13APPNAPPIAN CORPJ Other—

Recent filings

12

Companies

68

Address

1119 ST. PAUL STREET

BALTIMORE, MD, 21202